Example: Heart Attack

Search clinical trials for: Penicillamine

Total 12 results

NCT00552630

Withdrawn

Penicillamine Chelation for Children With Lead Poisoning

Conditions: Lead Poisoning; Vitamin D Deficiency
NCT00003751

Completed

Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma

Conditions: Brain and Central Nervous System Tumors
NCT01374282

No longer available

Post Marketing Surveillance Study of Cuprimine

Conditions: Scleroderma
NCT03539952

Active, not recruiting

Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease

Conditions: Wilson Disease
NCT03106948

Unknown status

Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis

Conditions: Arteriovenous Fistula Occlusion
NCT02125721

Completed

Effect of Increasing Doses of Cystine Binding Thiol Drugs on Cystine Capacity in Patients With Cystinuria

Conditions: Cystinuria
NCT02426905

Unknown status

Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine

Conditions: Wilson Disease
NCT03957720

Recruiting

The Individual Therapy for Patients With Wilson's Disease

Conditions: Wilson's Disease
NCT02763215

Completed

The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment

Conditions: Wilson Disease
NCT03403205

Active, not recruiting

Efficacy and Safety of ALXN1840 (Formerly Named WTX101) Administered for 48 Weeks Versus Standard of Care in Patients With Wilson Disease With an Extension Period of up to 60 Months

Conditions: Wilson Disease
NCT03660059

Active, not recruiting

A Study to Assess Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)

Conditions: Rheumatoid Arthritis (RA)
NCT02120105

Completed

Cystine Capacity Clinical Study (CysCap)

Conditions: Cystinuria